{"id":873551,"date":"2025-08-08T16:04:28","date_gmt":"2025-08-08T20:04:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/"},"modified":"2025-08-08T16:04:28","modified_gmt":"2025-08-08T20:04:28","slug":"compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/","title":{"rendered":"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON, Aug.  08, 2025  (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its financial results for the quarter ended\u00a0June 30, 2025 and host a webcast and conference call to provide an update on the ongoing tovecimig Phase 2\/3 study, clinical data for CTX-8371 and preclinical data for CTX-10726, on\u00a0Monday, August 11, 2025, at\u00a08:00 a.m. ET.<\/p>\n<p>\n        <strong>Call Details:<\/strong>\n      <\/p>\n<p>Date: Monday, August 11, 2025<\/p>\n<p>Time: 8:00 AM ET<\/p>\n<p>Webcast:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Mww7glBoDwvwkmQGR9O8wHbQ39nbUuoCexnlMdkyRDTiR9WLZRb3MdOtTY_4Orw-5I-jwGIHZSkvzya6zOL9l3QqlMaEdTjGaOMOWCAGcycREnjiNhRwFTK9YJKosb2O7t1_HDTM7eUjSSOqTMyzCVBQ5RuCp4SlgJrveVuvdj1feRRKQZaplbM96vJU5AnLMhrBIPYrvpJbH9iERCytIsb8YnBiVxCTp7iI10PYnAM=\" rel=\"nofollow\" target=\"_blank\">https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1727543&amp;tp_key=955a2c2f4d<\/a><\/p>\n<p>Dial-In: 1-877-407-9716 (US), 1-201-493-6779 (International), 13754954 (Conference ID)<\/p>\n<p>Virtual\/Replay availability: A replay will be archived for 90 days on Compass\u2019\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PTpueEN6CwlPDV37yyrSMpliYPBEHvC3b9RKZRKQ0GIGJgteik2c2eqFHYf3hI9lHSGSlBYO3FVBsCaRLtsVfb8bz5LV71Y8qvTL4vKp20P4JAoeiAQtC1yeQXkM346bLh7ZGxui18MLUWZKzYdTcruH6l03i7kwHPjnZgVox0cvnEzYnQXzucEPj1Ge4rOO7LCFrRAbiBKqSp_dSwFlGkVGZ9my-f-11dp0Rmgv2e0LGwI7zz57NnGnBG0l2IOUISPpmWpqVKPdm6xxCyoWeQ==\" rel=\"nofollow\" target=\"_blank\"><strong>Events<\/strong><\/a>\u00a0page.<\/p>\n<p>\n        <strong>About Compass Therapeutics<\/strong>\n      <\/p>\n<p>Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company\u2019s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The Company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at\u00a0https:\/\/www.compasstherapeutics.com.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>ir@compasstherapeutics.com<br \/><strong>Media Contact<\/strong><br \/>Anna Gifford, Chief of Staff<br \/>media@compasstherapeutics.com<br \/>617-500-8099<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZWMyYjYxMWItY2MyZi00NGE3LTk3NmUtMmIxNDk4YmQ3ZDEwLTEyMTM5NzUtMjAyNS0wOC0wOC1lbg==\/tiny\/Compass-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its financial results for the quarter ended\u00a0June 30, 2025 and host a webcast and conference call to provide an update on the ongoing tovecimig Phase 2\/3 study, clinical data for CTX-8371 and preclinical data for CTX-10726, on\u00a0Monday, August 11, 2025, at\u00a08:00 a.m. ET. Call Details: Date: Monday, August 11, 2025 Time: 8:00 AM ET Webcast:\u00a0https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1727543&amp;tp_key=955a2c2f4d Dial-In: 1-877-407-9716 (US), 1-201-493-6779 (International), 13754954 (Conference ID) Virtual\/Replay availability: A replay will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-873551","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its financial results for the quarter ended\u00a0June 30, 2025 and host a webcast and conference call to provide an update on the ongoing tovecimig Phase 2\/3 study, clinical data for CTX-8371 and preclinical data for CTX-10726, on\u00a0Monday, August 11, 2025, at\u00a08:00 a.m. ET. Call Details: Date: Monday, August 11, 2025 Time: 8:00 AM ET Webcast:\u00a0https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1727543&amp;tp_key=955a2c2f4d Dial-In: 1-877-407-9716 (US), 1-201-493-6779 (International), 13754954 (Conference ID) Virtual\/Replay availability: A replay will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The &hellip; Continue reading &quot;Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-08T20:04:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025\",\"datePublished\":\"2025-08-08T20:04:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/\",\"name\":\"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=\",\"datePublished\":\"2025-08-08T20:04:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/","og_locale":"en_US","og_type":"article","og_title":"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 - Market Newsdesk","og_description":"BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, will release its financial results for the quarter ended\u00a0June 30, 2025 and host a webcast and conference call to provide an update on the ongoing tovecimig Phase 2\/3 study, clinical data for CTX-8371 and preclinical data for CTX-10726, on\u00a0Monday, August 11, 2025, at\u00a08:00 a.m. ET. Call Details: Date: Monday, August 11, 2025 Time: 8:00 AM ET Webcast:\u00a0https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1727543&amp;tp_key=955a2c2f4d Dial-In: 1-877-407-9716 (US), 1-201-493-6779 (International), 13754954 (Conference ID) Virtual\/Replay availability: A replay will be archived for 90 days on Compass\u2019\u00a0Events\u00a0page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The &hellip; Continue reading \"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-08T20:04:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025","datePublished":"2025-08-08T20:04:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/","name":"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=","datePublished":"2025-08-08T20:04:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwODU5OSM3MDg4NjE3IzIyMDI0MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-present-second-quarter-financial-results-and-provide-business-update-on-august-11-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Compass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/873551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=873551"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/873551\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=873551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=873551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=873551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}